Intra-Cellular Therapies, Inc.

NasdaqGS:ITCI Stock Report

Market Cap: US$9.1b

Intra-Cellular Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ITCI?
Owner TypeNumber of SharesOwnership Percentage
State or Government44,9700.0424%
General Public2,075,8141.96%
Individual Insiders2,236,6242.11%
Institutions101,659,69595.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.

Top Shareholders

Top 25 shareholders own 68.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
FMR LLC
11,116,229US$952.5m-1.03%0.05%
9.08%
The Vanguard Group, Inc.
9,628,253US$825.0m0.22%0.01%
5.87%
BlackRock, Inc.
6,219,077US$532.9m-1.62%0.01%
4.87%
JP Morgan Asset Management
5,165,365US$442.6m52.1%0.05%
4.47%
Alafi Capital Company LLC
4,743,770US$406.5m0%100.0%
3.63%
Wasatch Advisors LP
3,848,588US$329.8m3.51%1.09%
2.88%
Avoro Capital Advisors LLC
3,050,000US$261.4m1.67%3.5%
2.8%
Invesco Ltd.
2,965,239US$254.1m5.47%0.07%
2.34%
Bellevue Asset Management AG
2,485,627US$213.0m0.58%2.51%
1.83%
Norges Bank Investment Management
1,943,730US$166.6m0%0.01%
1.75%
State Street Global Advisors, Inc.
1,858,915US$159.3m3.14%0.01%
1.63%
ClearBridge Investments, LLC
1,729,729US$148.2m0.47%0.11%
1.61%
Geode Capital Management, LLC
1,708,301US$146.4m1.31%0.01%
1.53%
Perceptive Advisors LLC
1,622,215US$139.0m-5.49%3.0%
1.53%
Pictet Asset Management Limited
1,619,268US$138.8m29%0.12%
1.51%
Deep Track Capital, LP
1,600,693US$137.2m4.08%4.12%
1.42%
Franklin Resources, Inc.
1,507,506US$129.2m8.53%0.04%
1.36%
Suvretta Capital Management, LLC
1,439,026US$123.3m-8.11%4.41%
1.32%
GW&K Investment Management, LLC
1,394,196US$119.5m0.02%0.93%
1.29%
Holocene Advisors, LP
1,370,831US$117.5m-7.36%0.45%
1.14%
AllianceBernstein L.P.
1,208,338US$103.5m-11.6%0.03%
1.1%
Marshall Wace LLP
1,160,973US$99.5m133%0.14%
1.09%
Westfield Capital Management Company, L.P.
1,159,356US$99.3m11.2%0.41%
1.01%
Sharon Mates
1,070,329US$91.7m0%no data
0.98%
T. Rowe Price Group, Inc.
1,042,455US$89.3m-27%0.01%